CLOV Q4 Earnings Beat Estimates, Sales Miss, Membership Rises

Clover Health Investments, Corp. (CLOV) delivered a fourth-quarter 2024 loss per share of 4 cents, narrower than the year-ago period’s loss of 14 cents. The bottom line beat the Zacks Consensus Estimate of a loss of 7 cents.Adjusted earnings per share from continuing operations were approximately 2 cents against a loss of 5 cents in the year-ago period.CLOV’s Revenues in DetailClover Health registered revenues of $337 million, up 7.9% year over year. However, the figure missed the Zacks Consensus Estimate b ...